Prediction of cardioembolic, arterial, and lacunar causes of cryptogenic stroke by gene expression and infarct location.
Prediction of cardioembolic, arterial, and lacunar causes of cryptogenic stroke by gene expression and infarct location.
复制标题
通过基因表达和梗塞位置预测隐源性中风的心脏栓塞、动脉和腔隙原因。
DOI:
10.1161/strokeaha.111.648725
复制
发表时间:
2012-08
期刊:
影响因子:
8.3
通讯作者:
Sharp FR
中科院分区:
文献类型:
--
作者:
Jickling GC;Stamova B;Ander BP;Zhan X;Liu D;Sison SM;Verro P;Sharp FR
The cause of ischemic stroke remains unclear, or cryptogenic, in as many as 35% of stroke patients. Not knowing the cause of stroke restricts optimal implementation of prevention therapy and limits stroke research. We demonstrate how gene expression profiles in blood can be used in conjunction with a measure of infarct location on neuroimaging to predict a probable cause in cryptogenic stroke. The cause of cryptogenic stroke was predicted using previously described profiles of differentially expressed genes characteristic of patients with cardioembolic, arterial and lacunar stroke. RNA was isolated from peripheral blood of 131 cryptogenic strokes and compared to profiles derived from 149 strokes of known cause. Each sample was run on Affymetrix U133 Plus2.0 microarrays. Cause of cryptogenic stroke was predicted using gene expression in blood and infarct location. Cryptogenic strokes were predicted to be 58% cardioembolic, 18% arterial, 12% lacunar and 12% unclear etiology. Cryptogenic stroke of predicted cardioembolic etiology had more prior myocardial infarction and higher CHA2DS2-VASc scores compared to stroke of predicted arterial etiology. Predicted lacunar strokes had higher systolic and diastolic blood pressures and lower NIHSS compared to predicted arterial and cardioembolic strokes. Cryptogenic strokes of unclear predicted etiology were less likely to have a prior TIA or ischemic stroke. Gene expression in conjunction with a measure of infarct location can predict a probable cause in cryptogenic strokes. Predicted groups require further evaluation to determine whether relevant clinical, imaging, or therapeutic differences exist for each group.